Drug intelligence / Profile preview

acetaminophen + codeine vs acetaminophen + oxycodone

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

This entry refers to the comparison between two combination analgesic drugs used for pain management: - **Acetaminophen + codeine** is a combination of an opioid (codeine) and a non-opioid analgesic (acetaminophen), indicated for mild to moderate pain. Codeine acts as a weak opioid agonist, while acetaminophen inhibits prostaglandin synthesis in the central nervous system[1][3][5]. - **Acetaminophen + oxycodone** combines a stronger opioid (oxycodone) with acetaminophen, used for moderate to severe pain. Oxycodone is a potent mu-opioid receptor agonist, and acetaminophen provides additional analgesia through central mechanisms[6][10]. Both combinations are available in oral formulations and are prescribed when other pain medications have not been effective or tolerated. Clinical studies indicate that both combinations provide significant short-term pain relief; however, direct comparisons show no statistically significant difference in efficacy or side-effect profile between them for acute extremity pain after emergency department discharge[8]. Oxycodone/acetaminophen may be more tightly regulated due to higher misuse potential.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetaminophen + codeine vs acetaminophen + oxycodone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + codeine vs acetaminophen + oxycodone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call